Pfizer/BioNTech’s COVID-19 Vaccine Moves Into Adolescents; Adcomm To Weigh Broader Pediatric Issues

 
• By Sue Sutter
  
Teenagers
US teenagers 12-15 years old are now eligible to receive Pfizer/BioNTech's COVID vaccine. • Source: Alamy
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet